<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><description>【国内外药讯，医药市场，医药数据分享】</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 11 Mar 2021 20:29:31 +0800</pubDate><image><url>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</url><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>烨辉医药​宣布与Ardeagen进行战略合作，共同开发多达3款ADC药物</title><link>https://mp.weixin.qq.com/s/Cx4Vj6b-foezObFdeAlKkg</link><description></description><content:encoded><![CDATA[烨辉医药​宣布与Ardeagen进行战略合作，共同开发多达3款ADC药物]]></content:encoded><pubDate>Thu, 11 Mar 2021 17:25:33 +0800</pubDate></item><item><title>应世生物与诗健生物宣布签订创新抗体药物研发战略合作协议</title><link>https://mp.weixin.qq.com/s/rPOJZxF9oLpWc7Gj6Ha1lA</link><description></description><content:encoded><![CDATA[应世生物与诗健生物宣布签订创新抗体药物研发战略合作协议]]></content:encoded><pubDate>Thu, 11 Mar 2021 17:25:33 +0800</pubDate></item><item><title>石药集团1.7亿元引进康诺亚一款IL-4Rα抗体中国大陆部分适应症权益</title><link>https://mp.weixin.qq.com/s/14OMKeKjPDNViyohXlmO1g</link><description></description><content:encoded><![CDATA[石药集团1.7亿元引进康诺亚一款IL-4Rα抗体中国大陆部分适应症权益]]></content:encoded><pubDate>Thu, 11 Mar 2021 17:25:33 +0800</pubDate></item><item><title>三代EGFR竞争来袭！石药2亿元引进一款！</title><link>https://mp.weixin.qq.com/s/eb-cXhAwkDMoBwWDV0pI4w</link><description></description><content:encoded><![CDATA[三代EGFR竞争来袭！石药2亿元引进一款！]]></content:encoded><pubDate>Wed, 10 Mar 2021 13:53:34 +0800</pubDate></item><item><title>估值超18亿元！高瓴押注这家CRO公司提交上市申请，尤启冬担任独立董事！</title><link>https://mp.weixin.qq.com/s/SA_HbgT54Cr8idHJJTt8vg</link><description></description><content:encoded><![CDATA[估值超18亿元！高瓴押注这家CRO公司提交上市申请，尤启冬担任独立董事！]]></content:encoded><pubDate>Tue, 09 Mar 2021 13:18:22 +0800</pubDate></item><item><title>估值超8亿美元，依生生物提交港股IPO申请！</title><link>https://mp.weixin.qq.com/s/gcM37fmTIu0ktNlb3ysErQ</link><description></description><content:encoded><![CDATA[估值超8亿美元，依生生物提交港股IPO申请！]]></content:encoded><pubDate>Tue, 09 Mar 2021 13:18:22 +0800</pubDate></item><item><title>超1.13亿元！通化东宝牵手药明康德，强势进军创新药领域</title><link>https://mp.weixin.qq.com/s/LCX8wVTx-TVk-kgy2XzCww</link><description></description><content:encoded><![CDATA[超1.13亿元！通化东宝牵手药明康德，强势进军创新药领域]]></content:encoded><pubDate>Mon, 08 Mar 2021 10:11:44 +0800</pubDate></item><item><title>香雪生命科学完成A轮1亿元融资，华盖医疗独家投资</title><link>https://mp.weixin.qq.com/s/EeFQrvs2IBPstwr7IL1zFQ</link><description></description><content:encoded><![CDATA[香雪生命科学完成A轮1亿元融资，华盖医疗独家投资]]></content:encoded><pubDate>Mon, 08 Mar 2021 10:11:44 +0800</pubDate></item><item><title>重磅！3900万美元押注Eirion，昊海生科拓展肉毒毒素产品线</title><link>https://mp.weixin.qq.com/s/olhxf7G-2PBIf7McPZmVZQ</link><description></description><content:encoded><![CDATA[重磅！3900万美元押注Eirion，昊海生科拓展肉毒毒素产品线]]></content:encoded><pubDate>Fri, 05 Mar 2021 11:51:22 +0800</pubDate></item><item><title>华人伉俪再次创业，A轮融资7100万美元</title><link>https://mp.weixin.qq.com/s/Qlep_UG__nhQ3pPvWEqxJA</link><description></description><content:encoded><![CDATA[华人伉俪再次创业，A轮融资7100万美元]]></content:encoded><pubDate>Fri, 05 Mar 2021 11:51:22 +0800</pubDate></item><item><title>3.4亿元打水漂！百奥泰终止3款临床阶段生物药临床开发</title><link>https://mp.weixin.qq.com/s/vNvo31gvkEdMIED1rLaNfQ</link><description></description><content:encoded><![CDATA[3.4亿元打水漂！百奥泰终止3款临床阶段生物药临床开发]]></content:encoded><pubDate>Fri, 05 Mar 2021 11:51:22 +0800</pubDate></item><item><title>重磅！君实生物PD-1抗体特瑞普利单抗滚动提交FDA上市申请</title><link>https://mp.weixin.qq.com/s/_kJM5q1krw5Mza3bwbGfww</link><description></description><content:encoded><![CDATA[重磅！君实生物PD-1抗体特瑞普利单抗滚动提交FDA上市申请]]></content:encoded><pubDate>Thu, 04 Mar 2021 11:33:59 +0800</pubDate></item><item><title>重磅！艾力斯三代EGFR抑制剂伏美替尼片获批上市！</title><link>https://mp.weixin.qq.com/s/YDDJPfV4iEX9TuSwpBmRnQ</link><description></description><content:encoded><![CDATA[重磅！艾力斯三代EGFR抑制剂伏美替尼片获批上市！]]></content:encoded><pubDate>Thu, 04 Mar 2021 11:33:59 +0800</pubDate></item><item><title>重磅！贝达药业三代EGFR抑制剂贝福替尼提交上市申请！</title><link>https://mp.weixin.qq.com/s/xK0EvEdzLc0-EDpp-ZUC8g</link><description></description><content:encoded><![CDATA[重磅！贝达药业三代EGFR抑制剂贝福替尼提交上市申请！]]></content:encoded><pubDate>Thu, 04 Mar 2021 11:33:59 +0800</pubDate></item><item><title>海思科750万美元引进一款奥氮平透皮贴剂</title><link>https://mp.weixin.qq.com/s/10OnaFWim4VQwG-fwa5j0g</link><description></description><content:encoded><![CDATA[海思科750万美元引进一款奥氮平透皮贴剂]]></content:encoded><pubDate>Mon, 01 Mar 2021 17:00:06 +0800</pubDate></item><item><title>前科伦博泰团队创立ADC新药公司完成3.5亿A轮融资</title><link>https://mp.weixin.qq.com/s/M-CUBl77fzh16NnbCmomxg</link><description></description><content:encoded><![CDATA[前科伦博泰团队创立ADC新药公司完成3.5亿A轮融资]]></content:encoded><pubDate>Mon, 01 Mar 2021 17:00:06 +0800</pubDate></item><item><title>首发：君实生物PD-1 与阿斯利康独家中国市场合作！</title><link>https://mp.weixin.qq.com/s/Xr1gY9ydTVxQaJhwx-usrw</link><description></description><content:encoded><![CDATA[首发：君实生物PD-1 与阿斯利康独家中国市场合作！]]></content:encoded><pubDate>Sun, 28 Feb 2021 17:12:17 +0800</pubDate></item><item><title>神速！刚刚，康希诺/军科院新冠病毒疫苗获批</title><link>https://mp.weixin.qq.com/s/DxTp1Ga2fgPBlQN2nXakdA</link><description></description><content:encoded><![CDATA[神速！刚刚，康希诺/军科院新冠病毒疫苗获批]]></content:encoded><pubDate>Thu, 25 Feb 2021 20:50:50 +0800</pubDate></item><item><title>重磅！康希诺生物新冠病毒疫苗有条件上市申请获受理</title><link>https://mp.weixin.qq.com/s/SwCOVkdH5MqouIgacVNcNg</link><description></description><content:encoded><![CDATA[重磅！康希诺生物新冠病毒疫苗有条件上市申请获受理]]></content:encoded><pubDate>Wed, 24 Feb 2021 13:32:53 +0800</pubDate></item><item><title>高瓴创投独立募资超100亿，一年出手超200起</title><link>https://mp.weixin.qq.com/s/efdaj0GeZtr2twN5VoeUNw</link><description></description><content:encoded><![CDATA[高瓴创投独立募资超100亿，一年出手超200起]]></content:encoded><pubDate>Wed, 24 Feb 2021 13:32:53 +0800</pubDate></item></channel></rss>